These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


438 related items for PubMed ID: 1975763

  • 1. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 2. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Lindefors N, Persson H, Ungerstedt U.
    Exp Brain Res; 1990 Jun 11; 82(2):293-303. PubMed ID: 1704847
    [Abstract] [Full Text] [Related]

  • 3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 11; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 4. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M, Herrera-Marschitz M, Hökfelt T, Terenius L, Ungerstedt U.
    Eur J Pharmacol; 1988 Mar 15; 147(3):411-20. PubMed ID: 2454197
    [Abstract] [Full Text] [Related]

  • 5. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS, Herrera-Marschitz M, Kehr J, Ungerstedt U.
    Acta Physiol Scand; 1990 Dec 15; 140(4):527-37. PubMed ID: 1707211
    [Abstract] [Full Text] [Related]

  • 6. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED, DeBoer P.
    J Neurosci; 1997 Nov 01; 17(21):8498-505. PubMed ID: 9334422
    [Abstract] [Full Text] [Related]

  • 7. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK, McGinty JF, Hong JS.
    Brain Res; 1990 Jan 15; 507(1):57-64. PubMed ID: 1967976
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.
    Fuxe K, O'Connor WT, Antonelli T, Osborne PG, Tanganelli S, Agnati LF, Ungerstedt U.
    Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5591-5. PubMed ID: 1535159
    [Abstract] [Full Text] [Related]

  • 9. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB, Herrera-Marschitz M, Nylander I, Goiny M, O'Connor WT, Ungerstedt U, Terenius L.
    Neuroscience; 1994 Nov 15; 63(2):427-34. PubMed ID: 7891856
    [Abstract] [Full Text] [Related]

  • 10. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors.
    Pollack AE, Wooten GF.
    Brain Res Mol Brain Res; 1992 Jan 15; 12(1-3):111-9. PubMed ID: 1312196
    [Abstract] [Full Text] [Related]

  • 11. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Jan 15; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 12. Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.
    Strömberg I, Bickford-Wimer P.
    Brain Res; 1991 Nov 15; 564(2):279-85. PubMed ID: 1687374
    [Abstract] [Full Text] [Related]

  • 13. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS, Herrera-Marschitz M, Terenius L, Ungerstedt U.
    Brain Res; 1990 Sep 03; 526(2):228-34. PubMed ID: 1701682
    [Abstract] [Full Text] [Related]

  • 14. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M, Westerink BH.
    Eur J Pharmacol; 1991 Oct 29; 204(1):79-85. PubMed ID: 1687125
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neurons.
    Waszczak BL.
    Brain Res; 1990 Apr 09; 513(1):125-35. PubMed ID: 2140951
    [Abstract] [Full Text] [Related]

  • 16. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L.
    Synapse; 1990 Apr 09; 5(2):113-9. PubMed ID: 2137942
    [Abstract] [Full Text] [Related]

  • 17. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 18. The effect of apomorphine and pergolide on the potassium-evoked overflow of GABA in rat striatum studied by microdialysis.
    Tossman U, Ungerstedt U.
    Eur J Pharmacol; 1986 Apr 16; 123(2):295-8. PubMed ID: 3709666
    [Abstract] [Full Text] [Related]

  • 19. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat.
    Bronstein DM, Ye H, Pennypacker KR, Hudson PM, Hong JS.
    Brain Res Mol Brain Res; 1994 May 16; 23(3):191-203. PubMed ID: 7914658
    [Abstract] [Full Text] [Related]

  • 20. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS, Herrera-Marschitz M, Hökfelt T, Ohlin M, Valentino KL, Ungerstedt U.
    Neuroscience; 1990 May 16; 36(3):643-58. PubMed ID: 1700329
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.